Evidence map›Paper›PMID 33324939›Full record

Trial reportNeurological research and practice2020

Validation of a German version of the Cerebellar Cognitive Affective/ Schmahmann Syndrome Scale: preliminary version and study protocol.

Andreas Thieme, Sandra Roeske, Jennifer Faber, Patricia Sulzer, Martina Minnerop, Saskia Elben, Heike Jacobi, Kathrin Reetz, Imis Dogan, Miriam Barkhoff and 9 more

Open access · diamondAbstract readClinical Trial
In one paragraph

Trial report in Neurological research and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Cognitive-Affective Functions of the Cerebellum.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 2 countries.

Andreas ThiemeDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany.ORCID 0000-0001-6221-8601
Sandra RoeskeGerman Center for Neurodegenerative Diseases (DZNE) Bonn, Helmholtz Association, Venusberg-Campus 1, 53127 Bonn, Germany.
Jennifer FaberGerman Center for Neurodegenerative Diseases (DZNE) Bonn, Helmholtz Association, Venusberg-Campus 1, 53127 Bonn, Germany.
Patricia SulzerDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany.
Martina MinneropInstitute of Neuroscience and Medicine (INM-1), Research Centre Juelich, Wilhelm-Johnen-Str., 52425 Juelich, Germany.
Saskia ElbenDepartment of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty, Heinrich-Heine University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, Germany.
Heike JacobiDepartment of Neurology, Heidelberg University Hospital, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
Kathrin ReetzInstitute of Neuroscience and Medicine (INM-11), Research Centre Juelich, Wilhelm-Johnen-Str., 52425 Juelich, Germany.
Imis DoganInstitute of Neuroscience and Medicine (INM-11), Research Centre Juelich, Wilhelm-Johnen-Str., 52425 Juelich, Germany.
Miriam BarkhoffGerman Center for Neurodegenerative Diseases (DZNE) Bonn, Helmholtz Association, Venusberg-Campus 1, 53127 Bonn, Germany.
Juergen KonczakSchool of Kinesiology, University of Minnesota, 400 Cooke Hall 1900 University Ave S E, Minneapolis, MN 55455 USA.
Elke WondzinskiDepartment of Neurology and Neurorehabilitation, MediClin Fachklinik Rhein/ Ruhr, Auf der Roetsch 2, 45219 Essen, Germany.
Mario SieblerDepartment of Neurology and Neurorehabilitation, MediClin Fachklinik Rhein/ Ruhr, Auf der Roetsch 2, 45219 Essen, Germany.
Oliver MuellerPresent Address: Department of Neurosurgery, Klinikum Dortmund, Muensterstr. 240, 44145 Dortmund, Germany.
Ulrich SureDepartment of Neurosurgery, Essen University Hospital, University of Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany.
Jeremy D SchmahmannDepartment of Neurology, Ataxia Center, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114 USA.
Thomas KlockgetherGerman Center for Neurodegenerative Diseases (DZNE) Bonn, Helmholtz Association, Venusberg-Campus 1, 53127 Bonn, Germany.
Matthis SynofzikDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany.
Dagmar TimmannDepartment of Neurology, Essen University Hospital, University of Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany.
Essen University Hospital · DEGerman Center for Neurodegenerative Diseases · DEForschungszentrum Jülich · DERuhrlandklinik · DEUniversity Hospital Bonn · DEHarvard University · USHeidelberg University · DEHeinrich Heine University Düsseldorf · DEUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditionally, cerebellar disorders including ataxias have been associated with deficits in motor control and motor learning. Since the 1980's growing evidence has emerged that cerebellar diseases also impede cognitive and affective processes such as executive and linguistic functions, visuospatial abilities and regulation of emotion and affect. This combination of non-motor symptoms has been named

methodsA preliminary German version has been created from the original CCAS Scale using a standardized translation procedure. This version has been pre-tested in cerebellar patients and healthy controls including medical experts and laypersons to ensure that instructions are well understandable, and that no information has been lost or added during translation. This preliminary German version will be validated in a minimum of 65 patients with cerebellar disease and 65 matched healthy controls. We test whether selectivity and sensitivity of the German CCAS Scale is comparable to the original CCAS Scale using the same cut-off values for each of the test items, and the same pass/ fail criteria to determine the presence of CCAS. Furthermore, internal consistency, test-retest and interrater reliability will be evaluated. In addition, construct validity will be tested in a subset of patients and controls in whom detailed neuropsychological testing will be available. Secondary aims will be examination of possible correlations between clinical features (e.g. disease duration, clinical ataxia scores) and CCAS scores. PERSPECTIVE: The overall aim is to deliver a validated bedside test to screen for CCAS in German-speaking patients which can also be used in future natural history and therapeutic trials. STUDY REGISTRATION: The study is registered at the German Clinical Study Register (DRKS-ID: DRKS00016854).

Indexed as

AffectBedside testCerebellumCognitionHuman

Identifiers

PMID33324939
PMCPMC7650062
OpenAlexW3090909708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.